Navigation Links
Targanta Therapeutics to Have Significant Presence at 47th Annual ICAAC Meeting
Date:9/12/2007

Over 20 Targanta-Related Posters and Presentations Accepted to Meeting

CAMBRIDGE, Mass., Sept. 12 /PRNewswire/ -- Targanta Therapeutics Corporation today announced that 23 presentations will showcase its lead antibiotic candidate, oritavancin, and its antibiotic drug discovery platform at the upcoming 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), taking place in Chicago, September 17-20, 2007.

Thomas Parr, Ph.D., Chief Scientific Officer of Targanta Therapeutics commented on the meeting: "We are very proud of the body of data being presented on behalf of Targanta at ICAAC this year-a true testament, we believe, to the efforts and expertise of our scientists and collaborators. We continue to be encouraged by the breadth of data supporting the differentiating characteristics of oritavancin and are pleased to be able to present for the first time promising data on our pre-clinical osteomyelitis program."

Throughout the meeting, multiple posters will highlight the in vitro activity of oritavancin, Targanta's investigational antibiotic for the treatment of gram-positive infections, against a wide spectrum of antibiotic susceptible and resistant gram-positive bacteria. In addition, two presentations at ICAAC will highlight Targanta's proprietary drug discovery platform, which utilizes bisphosphonate prodrugs of antibiotics to generate molecules that deliver antibiotics directly to the bone.

The following abstracts have been accepted for poster or slide presentation at ICAAC:

Date Time Number Type Author Title

Monday, 12:00- A-49 Poster Lehoux PK-PD of Oritavancin

Sept. 17 1:00PM CDT (ORI) Against

Streptococcus pneumoniae

(SP) in a Murine-Pneumonia

Infection Model
'/>"/>

SOURCE Targanta Therapeutics Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
2. Emerging technology companies receive significant funding
3. Genzyme acquistion of Bone Care approved, significant impact forecast
4. BIO 2007: Wisconsin makes its presence felt
5. TDS trades markets to gain Duluth presence
6. West Coast VC Establishes Midwest Presence in Madison
7. Sony Bets Heavy on Wisconsin Digital Entertainment Presence
8. NameProtect releases annual list of top trademarkers
9. Doyle says new contracts saving state more than $16 million annually
10. Department of Commerce offers up to $1 million annually to aid tech entrepreneurs
11. Annual Bioethics Forum to explore genetic testing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)...rstCall/ -- InterMune, Inc.,(Nasdaq: ITMN ) annou...8,financial results and provide a business update ...me. A live conference call and webcast will be,hos...me day., To access the live teleconference, dial ...), conference ID# 57393097. To access the,webcast,...
(Date:7/24/2008)...Help Spearhead Growth, PITTSBURGH, July 24 /PRNew.../www.hmsinc.com ), pioneering health informatics s...been appointed vice president, sales., Dockrell b...ales,management and product distribution for a ran...armaceutical companies., "Karen has an impressive...
(Date:7/24/2008)...tCall/ -- Hologic, Inc.,(Nasdaq: HOLX ) today ann...er by its direct wholly-owned subsidiary, Thunder ...ve Technologies, Inc. (Nasdaq: TWTI ) at a,price ...ring period expired at 12:00 midnight, New York Ci...tender offer period expired,at 12:00 midnight, New...
(Date:7/24/2008)...tant Advance in Radiofrequency ...uly 24 /- PEAK Surgical, Inc., a,medi... dissection system,based on a proprietary technolo...ministration has granted the company 510(k) cleara...n general surgery. The PEAK Surgery System,combine...
Breaking Biology Technology:InterMune to Release Second Quarter 2008 Financial Results and Provide Business Update on July 31 2Health Monitoring Systems Appoints Karen S. Dockrell As VP, Sales 2Hologic Completes Cash Tender Offer for Third Wave Technologies, Inc. 2Hologic Completes Cash Tender Offer for Third Wave Technologies, Inc. 3Hologic Completes Cash Tender Offer for Third Wave Technologies, Inc. 4PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in General Surgery 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in General Surgery 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in General Surgery 4
..., Achieving Ultra Fast Liquid Chromatograph...een designed to achieve,Ultra-Fast HPLC by utili...pect, we are successful,in demonstrating high sp... to high pressure, while providing high,reliabil...t,LC systems., Smaller particle columns ...
...T.J. Higley and Roy Eksteen, Tosoh Bioscience LLC,... Lexigen Pharmaceuticals, Lexington, Massachusetts...uring method development, many variables are exami...s such as elution profile, peak shape, and recover...GLP protocols. During a recent method , r...
..., Introduction , It is well k...icles are , more efficient at the expense... packed with larger particles. The gain in ef...ing column length, which in turn results in shorte...pressure. , Recently, two lines of 5 micro...
... Key words: Amino Acids, RP-HPLC, Precolumn deri...pionic acid, Ultraviolet detection., , ...cids do not significantly absorb light in the UV/..., their analysis normally includes a derivatisati...cursor to yield a strong UV/Visible chromophore or...
Other Biology Technology:Prominence UFLC 2Prominence UFLC 3Prominence UFLC 4Prominence UFLC 5Prominence UFLC 6Prominence UFLC 7Prominence UFLC 8Mobile Phase Optimization for the Analysis of an Antibody-Based Fusion Protein and Aggregates using a TSKgel Super SW3000 Size-Exclusion Column 2Mobile Phase Optimization for the Analysis of an Antibody-Based Fusion Protein and Aggregates using a TSKgel Super SW3000 Size-Exclusion Column 3Three Micron TSK-GEL ODS-100V Columns for High Throughput LCMS 2ANALYSIS OF AMINO ACIDS BY REVERSED PHASE CHROMATOGRAPHY WITH PRECOLUMN DERIVATISATION AND UV/VISIBLE DETECTION 2ANALYSIS OF AMINO ACIDS BY REVERSED PHASE CHROMATOGRAPHY WITH PRECOLUMN DERIVATISATION AND UV/VISIBLE DETECTION 3
(Date:7/23/2008)...y 24, 2008 One of the reasons people on low-carbo...their intake of fructose, a type of sugar that can...earcher at UT Southwestern Medical Center. , D...l nutrition and lead author of a study appearing i...aid her team,s findings suggest that the right typ...
(Date:7/23/2008)... parasites living in three estuaries on the Pacifi...hers have determined that biomass of these parasit... more than 20 times. , Their findings, which cou...ications, appear in this week,s issue of the journ...atter that exists in a given habitat. It is expres...
(Date:7/23/2008)... recent study shows that popular fish oil suppleme..., acute wounds in human skin. But whether that eff...cted, remains a mystery. , The omega-3 fatty aci...efit cardiovascular health and other diseases rela...inflammatory properties. But insufficient inflamma...
(Date:7/23/2008)...alif.) - In a study of free-living and parasitic s...California and Baja California, a team of research...ra, the United States Geological Survey, and Princ...ss in those habitats exceeds that of top predators... which could have significant biomedical and ecolo...
Breaking Biology News(10 mins):Limiting fructose may boost weight loss, UT Southwestern researcher reports 2Limiting fructose may boost weight loss, UT Southwestern researcher reports 3Parasites outweigh predators in Pacific Coast estuaries 2Parasites outweigh predators in Pacific Coast estuaries 3Scientists suspect omega-3 fatty acids could slow acute wound healing 2Scientists suspect omega-3 fatty acids could slow acute wound healing 3Scientists suspect omega-3 fatty acids could slow acute wound healing 4Study shows parasites outweigh predators 2Study shows parasites outweigh predators 3Results of TRIUMPH 1 Trial of Viveta in Pulmonary Arterial Hypertension to Be Announced Before Market Open on Thursday November 1 2007 711 1Results of TRIUMPH 1 Trial of Viveta in Pulmonary Arterial Hypertension to Be Announced Before Market Open on Thursday November 1 2007 711 2Health Insurance Agents Warn Against Imposing a Health Care Reform Tax in California 5163 1Health Insurance Agents Warn Against Imposing a Health Care Reform Tax in California 5163 2Health Insurance Agents Warn Against Imposing a Health Care Reform Tax in California 5163 3Boston Scientific Announces Verdict in Cordis Litigation 5159 1Boston Scientific Announces Verdict in Cordis Litigation 5159 2Boston Scientific Announces Verdict in Cordis Litigation 5159 3Diverse Partners Renew Commitment to Reproductive Health Rights in Asia 5155 1Diverse Partners Renew Commitment to Reproductive Health Rights in Asia 5155 2Diverse Partners Renew Commitment to Reproductive Health Rights in Asia 5155 3
...ng and action originates from the electrical signa...ngle of circuits. At this fundamental level, scien...y have lacked tools to understand what,s going wro... Parkinson,s disease. New Stanford-led research pu... technique to directly control brain cell activity...
...n humans, scientists have found early indicators o...elated injuries caused by repetitive motion. , Th... and prevention of debilitating conditions such as...ew study from Temple University senior researchers...t, Stephen Carp, in the March issue of Clinical Sc...
...he Ludwig Institute for Cancer Research (LICR) and...hool of Medicine have made a breakthrough in ident...cording to a report published online today in Natu...y genes (the ,what,) within the genome, it cannot ...hen, and ,where, gene products are expressed. Howe...
...s thought to be caused by hypoglycemic coma actual...e coma, according to a study in rodents led by res..., The results are surprising, say the authors, and... of diabetics in hypoglycemic coma, though they ca...polated to humans. , Insulin is an essential ho...
Other Biology News:A 'traffic light' for neurons means 'go' for improving brain research 2A 'traffic light' for neurons means 'go' for improving brain research 3A 'traffic light' for neurons means 'go' for improving brain research 4Red flag for repetitive stress injuries identified for first time in humans 2Beyond the DNA: Chemical signatures reveal genetic switches in the genome 2Glucose triggers brain cell death in rats after hypoglycemic coma 2Glucose triggers brain cell death in rats after hypoglycemic coma 3